The taxanes are used alone or in combination with anthracyclines or platinum drugs to treat breast and ovarian cancer, respectively. Taxanes target microtubules in cancer cells and modifiers of taxane
CH; CH5126766, PD; PD0325901, PLX; PLX4720 IC50 (nM).Effects of RAF, MEK, and RAF/MEK inhibitors on cancer cell lines with or without RAS, BRAF, PIK3CA, or PTEN mutations.
preprocessed GDSC drug response data Raw data source: https://www.cancerrxgene.org/downloads/bulk_download Subset to the record with a higher AUC value If multiple entries are found for a given cell l
